good example for CXS:
GSK PLC has signed deals with two biotech companies as part of its bid to find new drugs outside its own laboratories. One is a potential $1.4 billion deal with California-based OncoMed Pharmaceuticals that would allow Glaxo access to its novel antibodies that target cancer stem cells. The other is a drug development deal with Belgium-based Galapagos NV for new anti-infective medicines against up to six targets.
